title: The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.
abstract: Hepatitis C Virus (HCV) and other plus-strand RNA viruses typically require the generation of a small number of negative genomes (20-100× lower than the positive genomes) for replication, making the less-abundant antigenome an attractive target for RNA interference(RNAi)-based therapy. Because of the complementarity of duplex short hairpin RNA/small interfering RNA (shRNA/siRNAs) with both genomic and anti-genomic viral RNA strands, and the potential of both shRNA strands to become part of the targeting complexes, preclinical RNAi studies cannot distinguish which viral strand is actually targeted in infected cells. Here, we addressed the question whether the negative HCV genome was bioaccessible to RNAi. We first screened for the most active shRNA molecules against the most conserved regions in the HCV genome, which were then used to generate asymmetric anti-HCV shRNAs that produce biologically active RNAi specifically directed against the genomic or antigenomic HCV sequences. Using this simple but powerful and effective method to screen for shRNA strand selectivity, we demonstrate that the antigenomic strand of HCV is not a viable RNAi target during HCV replication. These findings provide new insights into HCV biology and have important implications for the design of more effective and safer antiviral RNAi strategies seeking to target HCV and other viruses with similar replicative strategies.
authors: Department of Pediatrics, School of Medicine, Stanford University, 269 Pasteur Drive, Stanford, CA 94305, USA.
authors: Leszek
authors: L
authors: Lisowski
authors: Menashe
authors: M
authors: Elazar
authors: Kirk
authors: K
authors: Chu
authors: Jeffrey S
authors: JS
authors: Glenn
authors: Mark A
authors: MA
authors: Kay
mesh_terms: D002460:Cell Line; D016679:Genome, Viral; D016174:Hepacivirus / Q000235:genetics* / Q000502:physiology; D006801:Humans; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000737:chemistry; D014779:Virus Replication
chemical_list: D034741:RNA, Small Interfering
references: J Virol. 2004 Jul;78(14):7763-74
references: 15220450
references: J Virol. 2008 Mar;82(6):2938-51
references: 18199654
references: Liver Int. 2012 Feb;32(2):339-45
references: 22142261
references: Nat Rev Microbiol. 2008 May;6(5):363-74
references: 18414501
references: J Virol. 1998 Nov;72(11):8578-85
references: 9765396
references: J Virol. 2003 May;77(9):5487-92
references: 12692249
references: Proc Natl Acad Sci U S A. 2011 May 31;108(22):9208-13
references: 21576459
references: Virology. 1999 Oct 10;263(1):30-41
references: 10544080
references: J Hepatol. 2005 Aug;43(2):225-34
references: 15964661
references: Cell. 2012 Nov 9;151(4):900-911
references: 23141545
references: Adv Virus Res. 2004;63:71-180
references: 15530561
references: J Virol. 2007 Jan;81(2):669-76
references: 17079316
references: Nucleic Acids Res. 2005 Jul 26;33(13):4140-56
references: 16049023
references: Virus Res. 2004 Jun 1;102(1):19-25
references: 15068876
references: Virology. 2002 Feb 1;293(1):31-43
references: 11853397
references: J Virol. 2005 Nov;79(21):13594-605
references: 16227280
references: Mol Ther. 2006 Oct;14(4):485-93
references: 16872906
references: Hepatology. 1997 Nov;26(5):1328-37
references: 9362380
references: J Virol. 2006 Feb;80(4):1734-41
references: 16439530
references: FEBS J. 2005 Nov;272(22):5910-22
references: 16279954
references: J Viral Hepat. 2007 Feb;14(2):122-32
references: 17244252
references: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2718-23
references: 12594334
references: J Gen Virol. 2000 Jul;81(Pt 7):1631-48
references: 10859368
references: Hepatology. 2005 Oct;42(4):962-73
references: 16149085
references: J Virol. 2002 Jun;76(12):5974-84
references: 12021330
references: J Virol. 2005 Feb;79(3):1645-54
references: 15650190
references: J Virol. 2005 Jun;79(11):7050-8
references: 15890944
references: Nat Rev Microbiol. 2007 Jun;5(6):453-63
references: 17487147
references: Hepatology. 2010 Dec;52(6):1877-87
references: 20931557
references: J Clin Invest. 2010 Sep;120(9):3106-19
references: 20697157
references: Virology. 1997 Jan 20;227(2):439-46
references: 9018143
references: Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10773-7
references: 7504283
references: Curr Protoc Bioinformatics. 2006 Mar;Chapter 12:Unit 12.6
references: 18428759
references: J Viral Hepat. 2007 Mar;14(3):194-212
references: 17305886
references: Cell. 2005 Jul 1;121(7):1097-108
references: 15989958
references: Science. 2005 Jul 22;309(5734):623-6
references: 15947137
references: Virus Res. 2004 Jun 1;102(1):27-35
references: 15068877
references: Expert Opin Biol Ther. 2003 Jul;3(4):575-86
references: 12831363
references: Semin Liver Dis. 1995 Feb;15(1):41-63
references: 7597443
references: Cell. 2003 Oct 17;115(2):209-16
references: 14567918
references: J Virol. 2008 Mar;82(5):2182-95
references: 18094154
references: J Virol. 1992 May;66(5):3225-9
references: 1313927
references: Hum Mol Genet. 2012 Feb 1;21(3):577-85
references: 22038834
references: Retrovirology. 2006 Sep 04;3:57
references: 16948865
references: RNA. 2004 Sep;10(9):1337-51
references: 15273323
references: Biochem Biophys Res Commun. 1995 Oct 13;215(2):744-9
references: 7488017
references: Mol Ther. 2012 Sep;20(9):1724-36
references: 22617108
references: Lancet Infect Dis. 2005 Sep;5(9):558-67
references: 16122679
references: Cell. 2003 Oct 17;115(2):199-208
references: 14567917
references: Nucleic Acids Res. 2007;35(15):5154-64
references: 17660190
references: Nat Biotechnol. 2003 Jun;21(6):639-44
references: 12740585
references: Nature. 2006 May 25;441(7092):537-41
references: 16724069
references: PLoS Pathog. 2012;8(12):e1003056
references: 23236278
references: J Virol. 2003 Jan;77(1):810-2
references: 12477890